Feature Channels: Heart Disease

Filters close
Released: 21-Nov-2022 11:35 AM EST
Study finds that risk of myocarditis after SARS-CoV-2 vaccination is increased but very low
Canadian Medical Association Journal

A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered when vaccinating.

Newswise: UT Southwestern scientists among top 1% of highly cited researchers across the globe
Released: 18-Nov-2022 10:05 AM EST
UT Southwestern scientists among top 1% of highly cited researchers across the globe
UT Southwestern Medical Center

More than 20 UT Southwestern Medical Center scientists are among the 2022 Highly Cited Researchers listed in the top 1% of researchers from across the globe

Newswise: Cardiovascular Societies Give Significantly Fewer Awards to Women Physicians, Researchers
Released: 17-Nov-2022 3:20 PM EST
Cardiovascular Societies Give Significantly Fewer Awards to Women Physicians, Researchers
Cedars-Sinai

A study published this week in the Journal of the American College of Cardiology (JACC) found that seven major cardiovascular societies were more likely to distribute awards to men and white individuals when compared to women and those who identify as Asian, Hispanic/Latino, and Black.

   
Newswise: Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
15-Nov-2022 8:00 AM EST
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Mount Sinai Health System

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, or advanced heart valve disease, or carotid artery disease associated with certain types of strokes, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

Released: 17-Nov-2022 1:00 PM EST
Slower Heart Rate Protects against Heart Enlargement, Limits Exercise Capacity
American Physiological Society (APS)

A new study in mice showed that a slower heart rate may protect against enlargement of the heart, a condition that could become life-threatening if left untreated. The study is published ahead of print in Function.

Released: 17-Nov-2022 11:05 AM EST
Congenital heart disease through life: Experts explain changes to expect
Mayo Clinic

Sixty years ago, treatment options were few for a child born with a structural heart defect. Innovations in therapies have since transformed congenital heart disease into a condition that often can be managed throughout adulthood. In this expert alert, Mayo Clinic cardiologists explain how the disease may change over a lifetime.

Released: 17-Nov-2022 10:15 AM EST
Cleveland Researchers Discover New Oral Drug for Lowering Cholesterol
University Hospitals Cleveland Medical Center

After statins, the next leading class of medications for managing cholesterol are PCSK9 inhibitors. These highly effective agents help the body pull excess cholesterol from the blood, but unlike statins, which are available as oral agents, PCSK9 inhibitors can only be administered as shots, creating barriers to their use.

Released: 17-Nov-2022 7:05 AM EST
Cannabis users had worse bypass outcomes, increased amputation and opioid use
Michigan Medicine - University of Michigan

The use of cannabis may have a negative impact on outcomes for a common bypass surgery, a study suggests. Patients who used cannabis prior to lower extremity bypass had decreased patency, meaning the graft had a higher chance of becoming blocked or occluded, higher rate of amputation and opioid use after discharge.

Newswise: Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
14-Nov-2022 4:10 PM EST
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Vanderbilt University Medical Center

The researchers discovered that T-cells recognizing the cardiac antigen α-myosin are the mechanism for this complication, setting the framework to identify biomarkers so at-risk patients can be recognized and medical strategies developed for them to tolerate the immunotherapy. Their findings are reported Nov. 16 in Nature.

Released: 15-Nov-2022 6:30 PM EST
Flu shots can protect patients with heart failure from death
McMaster University

An international study led by McMaster University researchers and published in The Lancet Global Health has found that influenza vaccines greatly reduce both pneumonia and cardiovascular complications in people with heart failure. An international study led by McMaster University researchers and published in The Lancet Global Health has found that influenza vaccines greatly reduce both pneumonia and cardiovascular complications in people with heart failure. Data gathered during flu season also showed the vaccine helped protect against cardiovascular complications, such as heart attacks and strokes.

Released: 15-Nov-2022 12:05 PM EST
UC Davis Health and Illuminate implement abdominal aortic aneurysm surveillance program
UC Davis Health (Defunct)

UC Davis Health and AI software company Illuminate have developed a centralized abdominal aortic aneurysm surveillance program using artificial intelligence software. The effort identifies at-risk abdominal aortic aneurysm patients who may have been ‘lost-to-follow-up’ either due to COVID-19 or other factors.

   
Newswise: Genes to Potentially Diagnose Long-Term Lyme Disease Identified
14-Nov-2022 3:00 PM EST
Genes to Potentially Diagnose Long-Term Lyme Disease Identified
Mount Sinai Health System

Researchers at the Icahn Mount Sinai have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease. These genes could potentially be used as biomarkers to diagnose patients with the condition, which is otherwise difficult to diagnose and treat. The findings, published November 15 in the journal Cell Reports Medicine, may also lead to new therapeutic targets. The study is the first to use transcriptomics as a blood test to measure RNA levels in patients with long-term Lyme disease.

Released: 14-Nov-2022 7:10 PM EST
Morning physical activity is associated with the lowest risk of heart disease and stroke
European Society of Cardiology

Morning physical activity is associated with the lowest risk of heart disease and stroke, according to a study in more than 85,000 individuals published today in the European Journal of Preventive Cardiology, a journal of the ESC.1

Released: 14-Nov-2022 4:25 PM EST
Bariatric Surgery Decreases Risk of Heart Disease
Rutgers University-New Brunswick

A Rutgers study of obese adults, all with nonalcoholic fatty liver disease (NAFLD) and morbid obesity (body mass index > 40), has shown that those who underwent bariatric surgery suffered far fewer extreme cardiovascular events subsequently.

Newswise: Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart
Released: 14-Nov-2022 1:40 PM EST
Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart
University of Maryland School of Medicine

UMSOM Researchers Report on New Findings from Heart Monitoring Systems at American Heart Association Meeting

Released: 14-Nov-2022 12:00 PM EST
AI transforms smartwatch ECG signals into a diagnostic tool for heart failure
Mayo Clinic

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence (AI) to Apple Watch ECG recordings to identify patients with a weak heart pump. Participants in the study recorded their smartwatch ECGs remotely whenever they wanted, from wherever they were. Periodically, they uploaded the ECGs to their electronic health records automatically and securely via a smartphone app developed by Mayo Clinic’s Center for Digital Health.

Released: 11-Nov-2022 11:40 AM EST
UChicago Medicine first in state to offer novel super-saturated oxygen therapy to patients with ‘widowmaker’ heart attacks
University of Chicago Medical Center

The treatment is the first therapy to mitigate heart muscle damage after catheter-based intervention and could increase long-term survival for heart attack patients.

Newswise:Video Embedded diabetes-awareness-month
VIDEO
Released: 10-Nov-2022 5:10 PM EST
Diabetes Awareness Month
Cedars-Sinai

Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.

Released: 10-Nov-2022 11:30 AM EST
Dermatology appointment leads to life-saving cardiac care
American Academy of Dermatology

Christopher Bengson MD, MHS, FAAD, a board-certified dermatologist for the Indian Health Service in Phoenix, Ariz., and a Commander in the U.S. Public Health Service, was named an American Academy of Dermatology Patient Care Hero for making a life-saving recommendation that prevented a heart attack in a psoriasis patient.

Released: 9-Nov-2022 4:05 PM EST
Study shows heart failure treatment with dapagliflozin consistently benefited both men and women
Brigham and Women’s Hospital

When it comes to heart failure (HF), sex differences are known to impact everything from risk factors to clinical presentation to response to treatment, making sex a key factor to consider in studies of emerging pharmacotherapies.

Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Newswise: Estudio: Durante la Pandemia, Disminuyó el Control de la Presión Arterial
Released: 9-Nov-2022 12:55 PM EST
Estudio: Durante la Pandemia, Disminuyó el Control de la Presión Arterial
Cedars-Sinai

De acuerdo a un nuevo análisis dirigido por investigadores de Cedars-Sinai y llevado a cabo en tres grandes sistemas de salud, el control y manejo de la hipertensión empeoraron durante los primeros meses de la pandemia de COVID-19.

Released: 9-Nov-2022 11:25 AM EST
Screening for stroke risk can save lives and money
Linkoping University

Atrial fibrillation is the greatest risk factor for stroke. Screening to detect atrial fibrillation in older people would not only increase the chance of preventing stroke, it would also save money for the healthcare system and society.

Released: 9-Nov-2022 10:55 AM EST
Severe obesity in youth a risk factor for early atrial fibrillation
University of Gothenburg

Severe or morbid obesity at age 18 may be linked to an elevated risk of atrial fibrillation in younger middle age. This is shown by a University of Gothenburg study comprising data on roughly 1.7 million men in Sweden.

Released: 8-Nov-2022 12:50 PM EST
Study Finds Most Fetal Congenital Heart Block Screening Fails to Meet Guidelines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

Released: 8-Nov-2022 12:05 PM EST
Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.

Newswise: National study suggests it’s time to rethink how we treat atrial fibrillation
Released: 7-Nov-2022 7:30 PM EST
National study suggests it’s time to rethink how we treat atrial fibrillation
University of British Columbia

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.

Newswise: How a SARS-CoV-2 Virus Protein Damages the Heart
Released: 7-Nov-2022 7:05 PM EST
How a SARS-CoV-2 Virus Protein Damages the Heart
University of Maryland School of Medicine

Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

Released: 7-Nov-2022 6:05 PM EST
Restored blood flow meant less pain, better quality of life for those with leg artery disease
American Heart Association (AHA)

estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.

Released: 7-Nov-2022 5:40 PM EST
دراسة تسلط الضوء على جينوم أمراض الشريان التاجي في الشرق الأوسط
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا — في دراسة جديدة من دراسات الروابط على نطاق الجينوم الخاصة بأمراض الشريان التاجي للمقيمين في قطر، لقد ألقى الباحثون الضوء على البنية الجينية للمرض في مجموعة سكانية محددة.

Released: 7-Nov-2022 2:35 PM EST
Clinical Trial Finds Novel Therapy Markedly Reduced Lipoprotein(a) Levels in People with Cardiovascular Disease
Brigham and Women’s Hospital

Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream.

Released: 7-Nov-2022 11:05 AM EST
Biases in cardiometabolic research put minority women's lives at risk
University of Michigan

Biases in heart disease and metabolic disorder—also known as cardiometabolic—studies are putting the lives of midlife Black and Hispanic women in jeopardy.

Released: 6-Nov-2022 6:30 PM EST
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
Duke Health

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

Released: 6-Nov-2022 9:15 AM EST
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Duke Health

For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for certain kinds of patients.

Released: 5-Nov-2022 10:30 AM EDT
Comparative Study of Two Heart Failure Drugs Finds No Difference in Outcomes
Duke Health

In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.

Newswise: November is National Hospice and Palliative Care Month - Find Out How Palliative Care Kept Family Connected During COVID-19
Released: 3-Nov-2022 3:10 PM EDT
November is National Hospice and Palliative Care Month - Find Out How Palliative Care Kept Family Connected During COVID-19
Hackensack Meridian Health

Team members facilitated FaceTime calls and provided comfort care for Nazli Ozkilic’s father, who was in long-term care due to congestive heart failure

Released: 3-Nov-2022 10:40 AM EDT
باحثو مايو كلينك يجدون أن وجود تاريخ من الإصابة بالسرطان أو مرض الشريان التاجي يساعد في تقليل خطر الإصابة بالخَرَف
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا -- تزداد مخاطر الإصابة بالخرف والسرطان وأمراض الأوعية الدموية مع التقدم في العمر، وكذا يزداد عدد سكان الولايات المتحدة من كبار السن. لكن العلاقة بين تلك الحالات المرضية ما تزال غير مفهومة بالكامل. في الآونة الأخيرة، أعلن باحثو مايو كلينك عن اكتشاف مثير للاهتمام مفاده: أن وجود تاريخ من الإصابة بالسرطان أو مرض الشريان التاجي قد يقلل من خطر الإصابة بالخرف. ونُشرت نتائج دراستهم في مجلة مرض الزهايمر.

Released: 3-Nov-2022 10:35 AM EDT
Descoberta de pesquisadores da Mayo Clinic revela que histórico de câncer ou doença arterial coronariana pode reduzir o risco de demência
Mayo Clinic

Os riscos de demência, câncer e doença arterial coronariana aumentam com o avanço da idade, e a população dos Estados Unidos está envelhecendo. Mas, até então, a conexão entre as condições não estava plenamente compreendida. Agora, os pesquisadores da Mayo Clinic relatam uma descoberta intrigante: ter histórico de câncer ou doença arterial coronariana pode reduzir o risco de demência. Os resultados do estudo foram publicados na revista médica Journal of Alzheimer's Disease.

Released: 3-Nov-2022 10:30 AM EDT
Investigadores de Mayo Clinic descubren que los antecedentes de cáncer o enfermedad de las arterias coronarias pueden reducir el riesgo de padecer demencia
Mayo Clinic

Los riesgos de padecer demencia, cáncer y enfermedades vasculares aumentan con la edad, y la población de los EE. UU. está envejeciendo. Sin embargo, no se comprende plenamente la conexión entre las afecciones. Ahora, los investigadores de Mayo Clinic informan un hallazgo interesante: tener antecedentes de cáncer o enfermedad de las arterias coronarias puede reducir el riesgo de padecer demencia. Los resultados del estudio están publicados en la revista Journal of Alzheimer's Disease.

Released: 3-Nov-2022 10:05 AM EDT
Breast Cancer Survivorship Doubles
University of Toronto

It was the information she couldn’t find that led Amy Kirkham, an assistant professor in the University of Toronto’s Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.

Newswise: “Heart in a Box” Technology Helps Northwestern Medicine Surgeons Perform a First-of-Its-Kind Transplant in Illinois
Released: 2-Nov-2022 5:00 PM EDT
“Heart in a Box” Technology Helps Northwestern Medicine Surgeons Perform a First-of-Its-Kind Transplant in Illinois
Northwestern Medicine

For the first time in Illinois, surgeons at Northwestern Medicine’s Bluhm Cardiovascular Institute successfully transplanted a heart donated after circulatory death (DCD).

Released: 2-Nov-2022 9:55 AM EDT
New 3D model shows how cadmium exposure may affect heart development
National Institute of Environmental Health Sciences (NIEHS)

Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead to congenital heart disease.

   
Released: 1-Nov-2022 7:35 PM EDT
Study Shows Blood Pressure Levels Rose During Pandemic
NIH, National Heart, Lung and Blood Institute (NHLBI)

Adults with hypertension saw a small, but consequential, rise in their blood pressure levels during the first eight months of the COVID-19 pandemic, while the number of times they had their blood pressure measured dropped significantly, according to a study supported by the National Institutes of Health.

Newswise: Smidt Heart Institute Experts to Present the Latest in Heart Research, Patient Care
Released: 1-Nov-2022 7:20 PM EDT
Smidt Heart Institute Experts to Present the Latest in Heart Research, Patient Care
Cedars-Sinai

Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.

Released: 1-Nov-2022 5:55 PM EDT
Getting to the Heart of COVID-19 Vaccination and Its Cardiovascular Risks
Elsevier

A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.

Newswise: Study: During Pandemic, High Blood Pressure Control Declined
Released: 1-Nov-2022 1:25 PM EDT
Study: During Pandemic, High Blood Pressure Control Declined
Cedars-Sinai

Hypertension control and management worsened during the early months of the COVID-19 pandemic, according to a new analysis conducted at three large health systems, led by Cedars-Sinai investigators.



close
2.80595